Analysis of tumor purity, the level of stromal cells that are present, and the infiltration level of immune cells resolved by ESTIMATE revealed that glioma samples with enhanced ISG20 expression manifested increased immune, stromal, and ESTIMATE scores (all P < 0.001; Fig. 6A). The gene discussed is ISG20; the disease is glioma.